Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysis

por Ekblad, Caroline M.S., Friedler, Assaf, Veprintsev, Dmitry, Weinberg, Richard L., Itzhaki, Laura S.
Publicado em 2004

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

por Andersen, Jan Terje, Pehrson, Rikard, Tolmachev, Vladimir, Daba, Muluneh Bekele, Abrahmsén, Lars, Ekblad, Caroline
Publicado em 2011

N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity

por Lindgren, Joel, Wahlström, Anna, Danielsson, Jens, Markova, Natalia, Ekblad, Caroline, Gräslund, Astrid, Abrahmsén, Lars, Karlström, Amelie Eriksson, Wärmländer, Sebastian KTS
Publicado em 2010

An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein

por Seijsing, Johan, Lindborg, Malin, Höidén-Guthenberg, Ingmarie, Bönisch, Heiko, Guneriusson, Elin, Frejd, Fredrik Y., Abrahmsén, Lars, Ekblad, Caroline, Löfblom, John, Uhlén, Mathias, Gräslund, Torbjörn
Publicado no Proc Natl Acad Sci U S A (2014)

Binding of EMSY to HP1β: implications for recruitment of HP1β and BS69

por Ekblad, Caroline M S, Chavali, Gayatri B, Basu, Balaka P, Freund, Stefan M V, Veprintsev, Dmitry, Hughes-Davies, Luke, Kouzarides, Tony, Doherty, Aidan J, Itzhaki, Laura S
Publicado em 2005

Early Implementation of QbD in Biopharmaceutical Development: A Practical Example

por Zurdo, Jesús, Arnell, Andreas, Obrezanova, Olga, Smith, Noel, Gómez de la Cuesta, Ramón, Gallagher, Thomas R. A., Michael, Rebecca, Stallwood, Yvette, Ekblad, Caroline, Abrahmsén, Lars, Höidén-Guthenberg, Ingmarie
Publicado no Biomed Res Int (2015)